Introduction
============

Intrahepatic cholangiocarcinoma (ICC) is a primary malignant tumor arising peripherally to the secondary bifurcation of the left or right hepatic duct. ICC is a relatively rare liver tumor when compared to hepatocellular carcinoma (HCC). ICC accounts for about 5--30% of primary liver tumors (Kaczynski et al., [@B13]; Yamamoto et al., [@B30]; Shaib and El-Serag, [@B25]). Surgical resection improves long-term survival in patients with ICC but the prognosis after aggressive resection remains unsatisfactory (Ohtsuka et al., [@B21]). Overall resectability rates were 54.6% in a study from Japan (Ikai et al., [@B11]) and 62% in a study from the United States (Weber et al., [@B29]) with the 1 and 3 year cumulative survival rates after resection being 49.4--76.6 and 17.3--52.7%, respectively (Fu et al., [@B6]; Shinohara et al., [@B26]; Choi et al., [@B4]; Lang et al., [@B15]). However, other methods such as radiotherapy have been examined in many retrospective series with promising results with respect to local control and survival benefit (Zeng et al., [@B31]; Chen et al., [@B3]; Jiang et al., [@B12]; Saxena et al., [@B23]). Adjuvant and definitive radiotherapy may play an important role in the treatment of ICC in the future.

Lymph node metastasis (LNM) has been reported to be a significant prognostic factor in ICC (Hanazaki et al., [@B9]; Fu et al., [@B6]; Nakagawa et al., [@B18]; Choi et al., [@B4]; Guglielmi et al., [@B8]; Saxena et al., [@B24]). It is also important to decide whether a patient with ICC should be considered for irradiation of the regional lymph nodes. If the absence of nodal metastasis is accurately detected, there would be no need for an extended irradiation field and thus the role of radiation therapy will become more significant. Therefore, identification of clinicopathologic factors that predict the status of lymph nodes in ICC could have potential clinical benefits. Till date, there are no accurate pre-operative factors that can predict LN metastasis. However, by using a combination of pre-operative factors, it might be possible to accurately categorize a subset of patients with no LNM.

In this study, 320 surgical cases with clinically negative lymph node (T~1--3~N~0~M~0~) ICC were analyzed and the factors associated with LNM were studied. The objectives of this study were to determine whether we could predict normal or metastatic lymph nodes using our approach and therefore avoiding unnecessary regional lymph node irradiation in selected patients with ICC.

Materials and Methods
=====================

Patients and diagnosis
----------------------

From January 2000 to January 2010, 370 patients with histologically proven ICC underwent hepatectomy at the Liver Cancer Institute, Zhongshan hospital, Fudan University. In this group, 320 patients had no metastasis to regional lymph nodes as per pre-operative images (CT/MRI). This study was approved by the ethical review board of Zhongshan Hospital, Fudan University.

Intrahepatic cholangiocarcinoma was confirmed by histopathological examination and the medical history and examination. HCC and metastasis from gastrointestinal cancers were ruled out by immunohistochemical staining for Hepa, CK7, CK19, CK20, alpha fetoprotein (AFP), MUC5AC, and MUC6. Positive staining for MUC5AC and CK7 together with negative staining for MUC6 and CK20 was suggestive of ICC. On the other hand, positive staining for MUC6 and CK20 combined with negative staining for MUC5AC and CK7 was suggestive of liver metastasis from colorectal cancer. The serum tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and AFP were also used as diagnostic tools to exclude HCC or mixed ICC/HCC.

Radiological images such as enhanced CT or MRI (or both) were used to assess the state of the tumor in the liver and to determine the tumor boundary, tumor size, and the presence of multiple nodules. We found that the boundary of ICC can be divided into two different forms based on radiological images: 1. During the arterial phase, ICC can have a distinct boundary, which appears as a regular border with a thin, ring-like iso-attenuated or enhanced structure relative to the liver (Figure [1](#F1){ref-type="fig"}A); 2. The second form has an obscure boundary that is characterized by an ill-defined border (Figure [1](#F1){ref-type="fig"}B). Assessment of tumor size was based on the largest dimension of the tumor. Multiple nodules were defined as the presence of two or more nodules, including intrahepatic metastases and satellite lesions. Nodal size is the current standard criteria for the defining LNM on imaging studies and lymph nodes measuring 1 cm or more in minimum diameter were regarded as metastatic. The following pre-operative demographics and clinical information were retrospectively obtained from patients' medical records: age, gender, and CA19-9. Tumor stage was defined according to the American Joint Committee on Cancer (AJCC) seventh edition staging for ICC (Nathan and Pawlik, [@B20]).

![**(A)** CT scan showing an intrahepatic cholangiocarcinoma that appears as a low-density area and has a regular, distinct boundary. **(B)** CT scan showing an intrahepatic cholangiocarcinoma with an obscure boundary.](fonc-01-00042-g001){#F1}

The locations of LNM were classified as reported by the Liver Cancer Study Group of Japan ([@B16]). The hilum, cystic duct, pericholedochal nodes, periportal nodes, and proper hepatic nodes around and in the hepatoduodenal ligament were grouped together as the hepatic hilum nodes (N1 group). The nodes in the pancreatic head and around the common hepatic artery and celiac trunk were defined as the N2 group. The N3 group was defined as the nodes around the para-aorta, major omenta, paracolic, and paramesenteric areas.

Statistical analysis
--------------------

In order to assess the factors which predict the probability of metastasis to lymph node, we first used univariate analysis (logistic regression model) to assess the following: age (less than 65 years, 65 years or older), gender, tumor boundary (distinct, obscure), the grade of differentiation (low: well to moderately; high: poorly to undifferentiated), tumor size (5 cm or less, more than 5 cm), multiple nodules, and CA19-9 (normal range: 37 ng/ml or less; abnormal value: more than 37 ng/ml). All variables which were significant (*P*-value less than 0.05) in the univariate analysis were entered in the multivariate analysis in order to discriminate the significant risk factors for LN metastases.

Receiver operating characteristic (ROC) curves were used to determine the predictive value of the parameters. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the accuracy were obtained for each of the testing method based on the binomial distribution.

All reported *P*-values are two sided. In both of the univariate and multivariate analyses, the relative risks (RRs) and their respective 95% confidence intervals (CIs) from the logistic regression model were reported. All statistical analyses were performed using SPSS, version 15.0 for Windows (Statistical Product and Services Solutions, SPSS Inc, Chicago, IL, USA). A value of *P* \< 0.05 was considered statistically significant.

Results
=======

Demographic data
----------------

There were 136 females and 184 males in this study. The median age was 56.9 ± 11.33 years (range 18--89 years). The tumor diameter ranged from 0.8 to 15 cm, with a median diameter of 6.1 ± 2.89 cm. 236 patients (73.8%) had a low-grade lesions and 84 patients (26.2%) had a high-grade lesions. The other patients' characteristics including tumor boundary, number of nodes, and CA19-9 are provided in Table [1](#T1){ref-type="table"}.

###### 

**Patient characteristics**.

  Characteristic                                            Number (%)
  --------------------------------------------------------- -------------
  Gender                                                    
        Female                                              136 (42.5%)
        Male                                                184 (57.5%)
  Age (years)                                               
        ≤65                                                 240 (75.0%)
        \>65                                                80 (25.0%)
  Tumor boundary                                            
        Distinct                                            155 (48.4%)
        Obscure                                             165 (51.6%)
  CA19-9 (U/L)                                              
        ≤37                                                 135 (42.2%)
        \>37                                                185 (57.8%)
  Tumor size (cm)                                           
        ≤5                                                  147 (45.9%)
        \>5                                                 173 (54.1%)
  Multiple nodules                                          
        No                                                  242 (75.6%)
        Yes                                                 78 (24.4%)
  Pathological differentiation                              
        Low (well to moderately differentiation)            236 (73.8%)
        High (poorly to undifferentiated differentiation)   84 (26.3%)
  Clinical staging                                          
        I                                                   200 (62.5%)
        II                                                  82 (25.6%)
        III                                                 38 (11.9%)
  Lymph node metastasis                                     
        No                                                  244 (76.3%)
        Yes                                                 76 (23.8%)

*CA19-9, carbohydrate antigen 19-9*.

Two hundred (62.5%) patients had stage I cancer, 82 (25.6%) had stage II cancer and 38 (11.9%) had stage III and staging was carried out according to the seventh edition of the UICC-TNM staging system for ICC.

Among all the 320 patients, 76 (23.8%) were confirmed to have LNM by pathological examination. The most common site of LNM was the hepatic hilum (N1, *n* = 54, 67.8%) while other sites were the peripancreatic head (N2, *n* = 17, 25.9%) as well as the para-aortic area and the major omenta (N3, *n* = 5, 6.3%).

Analysis of the factors associated with LNM
-------------------------------------------

In order to develop a model for predicting LNM, we first conducted a univariate analysis to test the predictive value of the following potential categorical predictors: gender, age, tumor boundary, tumor size, multiple nodules, histological differentiation, and CA19-9. As shown in the Table [2](#T2){ref-type="table"}, we found that LNM was associated with elevated CA19-9 (*P* = 0.017, RR = 1.955), tumor boundary (*P* = 0.01, RR = 2.512), tumor size (*P* = 0.005, RR = 2.202), and the histological differentiation (*P* \< 0.01, RR = 7.630).

###### 

**Results of the univariate analysis of factors associated with LNM**.

  Factor                                              RR      95% CI          *P*-value
  --------------------------------------------------- ------- --------------- -----------
  Gender                                                                      
        Female                                        1                       
        Male                                          0.671   0.400--1.126    0.131
  Age (years)                                                                 
        ≤65                                           1                       
        \>65                                          0.828   0.499--1.525    0.544
  Tumor boundary                                                              
        Distinct                                      1                       
        Obscure                                       2.512   1.456--4.333    0.001
  CA-199 (U/L)                                                                
        ≤37                                           1                       
        \>37                                          1.955   1.128--3.390    0.017
  Tumor size (cm)                                                             
        ≤5                                            1                       
        \>5                                           2.202   1.277--3.798    0.005
  Multiple nodules                                                            
        No                                            1                       
        Yes                                           1.368   0.767--2.439    0.289
  Pathological differentiation                                                
  Low (well to moderately differentiation)            1                       
  High (poorly to undifferentiated differentiation)   7.63    4.309--13.512   \<0.001

*RR, relative risk; CI, confidence interval; CA19-9, carbohydrate antigen 19-9; LNM, lymph node metastasis*.

All variables that were significant in the univariate analysis were selected and a multivariate analysis was conducted. The variables that reached significance in the multivariate analysis were the tumor size (*P* = 0.006, RR = 2.371), tumor boundary (*P* = 0.009, RR = 2.250) and histological differentiation (*P* \< 0.001, RR = 7.355; Table [3](#T3){ref-type="table"}). However, CA19-9 was not an independent factor for predicting LNM in multivariate analysis (RR = 0.674, *P* = 0.105).

###### 

**Results of the multivariate analysis of factors associated with LNM**.

  Factor                                              RR      95% CI          *P*-value
  --------------------------------------------------- ------- --------------- -----------
  Tumor boundary                                                              
        Distinct                                      1                       
        Obscure                                       2.25    1.224--4.137    0.009
  CA-199 (U/L)                                                                
        ≤37                                           1                       
        \>37                                          1.674   0.898--3.118    0.105
  Tumor size (cm)                                                             
        ≤5                                            1                       
        \>5                                           2.371   1.280--4.391    0.006
  Pathological differentiation                                                
  Low (well to moderately differentiation)            1                       
  High (poorly to undifferentiated differentiation)   7.355   4.053--13.348   \<0.001

*RR, relative risk; CI, confidence interval; CA19-9, carbohydrate antigen 19-9; LNM, lymph node metastasis*.

Prediction model for LNM using tumor boundary, tumor size, and histological differentiation
-------------------------------------------------------------------------------------------

Receiver operating characteristic curve analysis was performed for these predictive factors. The area under the curve (AUC) and the 95% CI were used to assess the power of these factors in predicting the LNM (Figure [2](#F2){ref-type="fig"}). ROC analysis showed that histological differentiation was accurate in predicting LNM (AUC: 0.716; 95% CI: 0.645--0.788; *P* \< 0.001), followed by tumor boundary (AUC: 0.611; 95% CI: 0.539--0.682; *P* = 0.004) and tumor size (AUC: 0.594; 95% CI: 0.522--0.666; *P* = 0.013; Table [4](#T4){ref-type="table"}).

![**Receiver operating characteristic analysis: ROC analysis of histological differentiation, tumor boundary, and tumor size**. The AUC of all parameters was less than 0.5, indicating that they were predictive of LNM.](fonc-01-00042-g002){#F2}

###### 

**Area under the curve demonstrating the discriminatory power of each factor for predicting LNM**.

  Factor                         AUC     SE     95% CI         *P*
  ------------------------------ ------- ------ -------------- ---------
  Pathological differentiation   0.716   0.37   0.645--0.788   \<0.001
  Tumor boundary                 0.611   0.36   0.539--0.682   0.004
  Tumor size                     0.594   0.37   0.522--0.666   0.013

*AUC, area under the curve; CI, confidence interval; LNM, lymph node metastasis; SE, standard error*.

The sensitivity/specificity, PPV/NPV, and the accuracy after the combination of two or three significant factors for LNM are summarized in Table [5](#T5){ref-type="table"}. Conspicuously, the sensitivity/specificity and PPV/NPV by combining the three factors (tumor boundary, tumor size, and histological differentiation) for LNM were 96.1/23.0 and 28.0/95.0%, respectively. Furthermore, the accuracy was 40.3%. This means that among the 59 patients (18.4%) who had none of these three risk factors, only three patients had LNM. For these specific patients, regional lymph node irradiation may be omitted during radiotherapy.

###### 

**Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of factors significant on multivariate analysis**.

                                                                             Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)   Accuracy (%)
  -------------------------------------------------------------------------- ----------------- ----------------- --------- --------- --------------
  Tumor size combined with tumor boundary                                    92.1              26.6              28.1      91.5      42.2
  Tumor size combined with pathological differentiation                      88.2              42.2              32.2      92.0      53.1
  Pathological differentiation combined with tumor boundary                  84.2              45.5              32.5      90.2      54.6
  Pathological differentiation combined with tumor boundary and Tumor size   96.1              23.0              28.0      95.0      40.3

Furthermore, we found that 73 patients (73/76, 90.1%) with LN metastasis had at least one risk factor: 18 patients had one risk factor, 34 patients had two risk factors, and 21 patients had three risk factors. 56 patients (56/244, 23.0%) without LN metastasis had no significant risk factors. In the remaining 188 patients without LN metastasis, 111 patients had one risk factor, 69 patients had two risk factors and 8 patients had three risk factors.

Discussion
==========

Unlike HCC, ICC is commonly associated with LNM. This study, which was conducted on a relative large number of patients and showed that the incidence of LNM for those patients without pre-operative node evaluation was 23.8% (76/320); LNM has been reported to be associated with poor prognosis in patients with ICC (Hanazaki et al., [@B9]; Fu et al., [@B6]; Zeng et al., [@B31]; Chen et al., [@B3]; Jiang et al., [@B12]; Saxena et al., [@B23]) plus it is also important in defining the target volume for the radiation oncologist.

Previous studies (Bluestein et al., [@B2]; Narayan et al., [@B19]; Fuwa et al., [@B7]) have developed models based on clinical or pathologic data so as to predict the risk of lymph node metastases for other cancers such as lung cancer and prostate cancer. This information is important so as to decide whether a cancer patient should undergo a staging lymphadenectomy (including laparoscopic technique) or directly considered for irradiation of the regional lymph nodes; however, limited data is available regarding ICC and LNM prediction. Since radiotherapy may play an important role in the treatment of ICC in the future, it is time to discuss how to delineate the target volume in patients with ICC. Therefore, the aim of this study was to try to determine whether we could accurately predict nodal status preoperatively in ICC and avoid unnecessary regional lymph node irradiation in selected patients. This study indicates that we can avoid unnecessary lymph node region irradiation in about 18.4% of patients with ICC who had none of the tested clinicopathologic factors.

In this study, we tried to analyze the correlation between clinicopathologic factors and LNM. Univariate analysis test showed that LNM was associated with histological differentiation, tumor boundary, tumor size, and CA19-9 serum levels. Multivariate logistic analysis revealed that only histological differentiation, tumor boundary, and tumor size, demonstrated aggressive tumor characteristics and were independent predictors for LNM. Histological differentiation and tumor size may be because of the biological behavior of ICC. Poor differentiated or undifferentiated tumors together with large tumor size points toward increased invasiveness. Even though few previous reports have described the type of tumor boundary on imaging for ICC, it was found to be a good predictor for microinvasion (Bi et al., [@B1]). In our study, tumor boundary is also associated with LNM. In addition, histological differentiation was a superior predictor of LNM as shown by a ROC-based approach.

Patients with elevated CA19-9 levels are more likely to develop recurrent disease and survive for a shorter time than patients with normal CA19-9 levels; higher CA19-9 levels are associated with more advanced TNM stages (Endo et al., [@B5]; Hatzaras et al., [@B10]). However, in our study, the CA19-9 value was found to be a significant factor based on the univariate analysis but not based on the multivariate analysis.

The overall accuracy for detecting metastatic lymph nodes by pre-operative imaging has been reported to be 57--82.2% (Hanazaki et al., [@B9]; Park et al., [@B22]; Kim et al., [@B14]). The most common error in pre-operative imaging is underestimation of the nodal involvement (Vilgrain, [@B28]). Therefore, combining the factors listed above may help improve pre-operative evaluation of LNM for patients with clinically negative lymph node. In our study, with the combination two of the three factors (tumor boundary, tumor size, and histological differentiation), the sensitivity and NPV were 84.2--92.1 and 90.2--92.0%, respectively. Considering the clinical significance of LN metastasis and its importance for the delineation of target volume, the tests required to predict LN metastasis should show high sensitivity and high NPV. The sensitivity and NPV of the three combined pre-operative criteria in our study reached 96.1 and 95%, respectively. This suggested that if a patient with a small tumor size (less than 5 cm), distinct tumor boundary and low-grade differentiation, the chance for LNM is very low (5%) and also indicates that regional lymph node irradiation may be omitted in these specific cases.

Technological advances in radiation planning, breathing motion reduction strategies, and image guidance have made it possible for radiation to be delivered conformally to focal liver cancers while reducing the risk of toxicity. Stereotactic body radiation therapy (SBRT), referring to an improved spatial distribution of the administered dose and delivering the potent radiation in fewer fractions, has also been used safely and efficiently for intrahepatic tumors (Mendez Romero et al., [@B17]; Tse et al., [@B27]). This is a highly attractive treatment option in a palliative situation where overall treatment time is significantly reduced. In our study, cases where the histological differentiation is low-grade, the tumor boundary is distinct, and the tumor size is less than 5 cm, the probability of LNM is low and for these patients SBRT may be a good choice.

The current study is limited because it is a small-scale retrospective hospital-based study at a single institution. Large-sized multi-center studies will be needed to confirm our results. Another important limitation of this study relates to the discrimination of tumor boundary. The classification of tumor boundary is highly subjective and therefore the inclusion of this factor could affect the accuracy of the prediction system. Consequently, a strict classification system is needed to define this parameter in the future. Finally, this large series was conducted over a long period (2000--2009); both diagnostic and therapeutic procedures for ICC have considerably changed over these years. Thus, these developments probably contributed to variance in the correlation between pre-operative characteristics and LNM.

In conclusion, it has been demonstrated that cases with low-grade differentiation, distinct tumor boundary and tumor size of no more than 5 cm, the probability of LNM is very low (5%). The tested combination of the three factors is useful for the prediction of patients without LN metastasis and we could safely omit regional lymph node irradiation in about a fifth of patients with ICC while these cases are also good candidates for SBRT.
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